Billion Dollar Club Archives - Page 3 of 54

ThursdayJul 16, 2026 10:00 am

Regional Conflict Puts Dubai Crypto Hub to the Test

Dubai has become one of the world's leading centers for cryptocurrency and blockchain businesses. Its business-friendly environment, clear regulations, and modern infrastructure have attracted many digital asset companies from around the world. However, the recent regional conflict has tested the city's ability to remain a trusted destination for the crypto industry. In late February, tensions in the Middle East increased after U.S.-Israeli strikes on Iran. Missile and drone activity near Dubai created uncertainty across the region. Many wealthy expatriates and cryptocurrency executives became concerned about their safety. Some chose to leave temporarily, paying for private flights to destinations such as…

TuesdayJul 14, 2026 10:00 am

Ford Provides a Peek at its New Electric Pickup Truck

Ford has shared new details about its future electric pickup truck, giving people a better idea of what to expect. Although the company has not revealed the truck's official name, it has confirmed that the vehicle will be the first model built on its new Universal Electric Vehicle platform. This marks an important step in Ford's plan to expand its electric vehicle lineup and meet the growing demand for cleaner transportation. One of the biggest questions is what the new truck will be called. Ford has kept the name a secret, but many believe the company could bring back the…

TuesdayJul 14, 2026 9:45 am

Why VERAXA Biotech AG (NASDAQ: VRXA) Could Benefit More Than Others From AI’s Growing Impact on Drug R&D

Artificial intelligence is becoming an increasingly important tool for drug discovery, with major pharmaceutical companies expanding AI collaborations across oncology and immunology. VERAXA Biotech has partnered with AI-focused contract research organization Ardigen to strengthen discovery efforts for its BiTAC(R) cancer therapy platform. The collaboration aims to identify optimal dual-target combinations for T-cell engagers and antibody-drug conjugates while reducing development risks. VERAXA's Boolean "AND-gated" BiTAC(R) technology presents a use case that may be particularly well suited for AI-assisted target selection and therapeutic design. AI analysis of historical clinical and preclinical datasets could help identify promising targets that were previously abandoned because…

FridayJul 10, 2026 10:00 am

Why Insurance Costs for EVs are Higher Than for Fossil Fuel Cars

One of the concerns that many people have about switching to EVs is the higher insurance premiums that motorists are required to pay in order to cover their vehicles. We discuss some of the measures that can be taken to reduce this cost and make EV ownership more appealing. For starters, there are fewer technicians skilled in repairing electric vehicles. This means that those few technicians charge a premium for their services, and this translates into higher insurance costs since repair bills ultimately get passed on to vehicle owners. One way to fix this is for manufacturers to work with…

ThursdayJul 09, 2026 10:00 am

Bitcoin ETFs Record First Half-Year of Net Outflows

Bitcoin spot exchange-traded funds posted their first negative six-month performance since entering the market, marking a notable shift after a prolonged period of consistent investor inflows. DWF Labs data shows that Bitcoin spot ETFs finished the first half of the year with net withdrawals totaling $5.4 billion. The decline follows two years of sustained demand that had pushed cumulative net inflows to $56.6 billion by the beginning of 2026. January alone recorded $1.6 billion in net outflows, and by February 23, total cumulative inflows had dropped to $53.8 billion. That represented a decline of $2.8 billion in under two months.…

WednesdayJul 08, 2026 10:30 am

VERAXA Biotech AG (NASDAQ: VRXA) Advances Lead BiTAC(R) T-Cell Engager Program with Cell Line Development Partnership

The company has initiated cell line development for its lead BiTAC(R) T-cell engager program, selecting ATUM to support manufacturing development as the candidate advances toward IND/CTA-enabling studies. ATUM will apply its Leap-In Transposase(R) technology to generate stable clonal cell lines for VERAXA's lead therapeutic candidate. The collaboration represents an important development milestone, supporting manufacturing, analytical development and nonclinical studies required before clinical testing. VERAXA's BiTAC(R) platform is designed to improve the selectivity of T-cell engagers, potentially reducing toxicity associated with conventional approaches. The company recently expanded its research facilities in Heidelberg, Germany, increasing laboratory capacity as multiple oncology programs move…

TuesdayJul 07, 2026 10:00 am

France to Relaunch its Social Leasing EV Program in July

France will relaunch the country’s social leasing electric vehicle (EV) program on July 16, 2026 as part of its effort to make electric cars more affordable for lower-income workers. The program is designed to help people who rely on private vehicles for work but cannot afford the high upfront cost of buying a new EV. Instead of purchasing a car, eligible drivers can lease one at a monthly cost of less than €200 ($228), making cleaner transportation more accessible. The program is available across Metropolitan France, the country's overseas departments and regions, and Saint-Pierre-et-Miquelon. It focuses on helping workers who…

MondayJul 06, 2026 10:00 am

South Korea Earmarks $1 Trillion for Chip, AI Investment

South Korea has announced one of its biggest technology investment plans ever. The country plans to spend more than $1 trillion over the coming years to strengthen its leadership in semiconductor chips and artificial intelligence (AI). The government believes this investment is necessary to stay ahead in the fast-growing global technology industry. President Lee Jae Myung introduced the plan as a major step toward securing South Korea's future. He said the country must move faster than other nations in developing the key technologies that will shape the world. The strategy focuses on three main areas: semiconductor chips, physical AI, and…

ThursdayJul 02, 2026 10:00 am

Why Wall Street Watches Jefferies’ Earnings Reports Closely

Jefferies Financial may not be as large as Wall Street giants like Goldman Sachs, Morgan Stanley, or JPMorgan Chase, but its earnings reports attract plenty of attention. Many investors and market analysts watch the company's financial results because they often provide an early look at how the investment banking industry is performing. Since Jefferies reports its earnings weeks before the biggest U.S. banks, its results can offer useful clues about what may happen when those larger institutions announce their own quarterly performance. One reason Jefferies is closely followed is that its financial quarter ends earlier than those of many major…

WednesdayJul 01, 2026 10:40 am

Why VERAXA Biotech AG (NASDAQ: VRXA) Shareholders Should Pay Serious Attention to Antibody Therapeutics Sector Deals

Deal activity remains strong in antibody-drug conjugates (ADCs) and T-cell engager (TCE) therapeutics, with pharmaceutical companies continuing to commit substantial capital to preclinical and early-stage innovation. The Jazz Pharmaceuticals–AbCellera collaboration illustrates how differentiated antibody technologies can command significant financial commitments before entering clinical development. VERAXA Biotech AG is positioning its technology platform across both ADCs and T-cell engagers, two therapeutic modalities that continue to attract strategic partnerships and acquisitions. Platform technologies and individual drug candidates both represent potential avenues for future partnering, licensing, and collaboration agreements. Recent transactions across the sector demonstrate that pharmaceutical companies are actively seeking access to…

The exclusive home of the biggest and brightest companies covered by IBN.

Contact us: (512) 354-7000

Category: Billion Dollar Club